FIS vs TARS · P/E 7.9, rev $6.67B vs rev $336.0M
Fidelity National Information Services Inc (FIS) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
FIS currently screens at market cap $21.12B and trailing P/E 7.9. TARS currently screens at market cap $2.66B.
Not investment advice. Open the FIS and TARS stock pages for the full models.
Not investment advice.